ALTIERI, Grazia Ida
ALTIERI, Grazia Ida
A NOVEL APOB MUTATION IDENTIFIED BY EXOME SEQUENCING COSEGREGATES WITH STEATOSIS, LIVER CANCER AND HYPOCHOLESTEROLEMIA
2013-01-01 Spina, R; Cefalù AB; Pirruccello, JP; Altieri, GI; Noto, D; Gabriel, S; Valenti, V; Gupta, N; Fayer, F; Palesano, O; Tarugi, P; Kathiresan, S; Averna, M
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: A possible role in glucocorticoid deficiency
2015-01-01 Spadaro, L.; Noto, D.; Privitera, G.; Tomaselli, T.; Fede, G.; Scicali, R.; Piro, S.; Fayer, F.; Altieri, I.; Averna, M.; Purrello, F.
Erratum: FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease (Analytical and Bioanalytical Chemistry DOI: 10.1007/s00216-015-9229-6)
2016-01-01 Francesca Di Gaudio; Sergio Indelicato; Roberto Monastero; Grazia Ida Altieri; Francesca Fayer; Ornella Palesano; Manuela Fontana; Angelo B. Cefalu; Massimiliano Greco; David Bongiorno; Serena Indelicato; Angela Aronica; Davide Noto; Maurizio Averna;
FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease
2016-01-01 Di Gaudio, F.; Indelicato, S.; Monastero, R.; Altieri, G.; Fayer, F.; Palesano, O.; Fontana, M.; Cefalù, A.; Greco, M.; Bongiorno, D.; Indelicato, S.; Aronica, A.; Noto, D.; Averna, M.
Genetic epidemiology of ARH in Sicily
2016-01-01 Spina, R.; Valenti, V.; Ingrassia, V.; La Spada, M.P.; Scrimali, C.; Misiano, G.; Noto, D.; Palesano, O.; Altieri, G.I.; Licata, V.; Fayer, F.; Barbagallo, C.M.; Cefalù, A.B.; Averna, M.
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily
2017-01-01 Giammanco, Antonina; Spina, Rossella; Ingrassia, Valeria; Valenti, Vincenza; Scrimali, Chiara; Misiano, Gabriella; Altieri, Grazia I.; Fayer, Francesca; Barbagallo, Carlo M.; Ganci, Antonina; Noto, Davide; Cefalu', Angelo B.; Averna, Maurizio
Identification of a novel ANGPTL3 mutation splicing associeted to severe hypobetalipoproteinemia
2012-01-01 Spina, R; Crisci, I; Valenti, V; Altieri, GI; Fayer, F; Barbagallo, CM; Noto, D; Cannizzaro, A; Miccoli, R; Cefalù, AB; Averna, M
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing
2017-01-01 Cefalu', A; Spina, R; Noto, D; Ingrassia, V.; Valenti, V; Giammanco, A; Fayer, F; Misiano, G; Cocorullo, G; Scrimali, C; Palesano, O; Altieri, G; Ganci, A; Barbagallo, C; Averna, M
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY
2019-01-01 Scrimali, C; Spina, R; Ingrassia, V; Cefalu, AB; Brucato, F; Misiano, G; Valenti, V; Noto, D; Altieri, GI; Fayer, F; Giammanco, A; Barbagallo, C; Averna, M
LA LIPIDOMICA DELLA NON ALCOHOLIC FATTY LIVER DISEASE: ANALISI DELLA CINETICA DELL’ACIDO PALMITICO MEDIANTE L’USO DI UN ISOTOPO STABILE IN UN MODELLO IN VITRO
2014-01-01 Altieri, I.; Indelicato, S.; Palesano, O.; Spina, R.; Misiano, G.; Valenti, V.; Ingrassia, V.; Fayer, F.; Cefalù, A.; Barbagallo, C.; Noto, D.; Gaudio, F.; Averna, M.
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS
2011-01-01 Greco M; Noto D; Petta S; Minà M; Fayer F; Altieri I; Valenti V; Spina R; Craxì A; Averna M
LIPIDOMICS OF HUMAN SKIN FIBROBLASTS IN NEIMANN-PICK DISEASE TYPE C
2013-01-01 Palesano, O; Noto, D; Indelicato, S; Fontana, M; Fayer, F; Altieri, I; Pinotti, E; Di Leo, E; Magnolo, L; Calandra, S; Tarugi, P; Di Gaudio, F; Averna, M
Metabolic disturbances and risk of cancer in the 25 years follow-up of the “Ventimiglia Heart Study” epidemiological project
2016-01-01 Noto, D.; Cefalù, A.B.; Barbagallo, C.M.; Giammanco, A.; Fayer, F.; Palesano, O.; Altieri, G.I.; Spina, R.; Valenti, V.; Pagano, M.; Cavera, G.; Averna, M.R.
Metabolomic analysis of plasma from Alzheimer disease patients
2011-01-01 Greco, M; Noto, D; Tralongo, P; Monastero, R; Fayer, F; Cannizzaro, A; Altieri, I; Palesano, O; Spina, R; Valenti, V; Cefalù, AB; Averna, M
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES"
2020-01-01 Brucato, F; Martinelli, N; Spina, R; Busti, F; Ingrassia, V; Scrimali, C; Altieri, GI; Noto, D; Misiano, G; Giammanco, A; Barbagallo, CM; Fayer, F; Cefalu, AB; Olivieri, O; Girelli, D; Averna, M
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS
2020-01-01 Giammanco, Antonina; Scrimali, C; Spina, R; Ingrassia, V; Brucato, F; Valenti, V; Cefalu, AB; Misiano, G; Altieri, GI; Noto, D; Barbagallo, CM; Ganci, A; Fayer, F; Averna, M
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY
2020-01-01 Scrimali, C; Spina, R; Ingrassia, V; Brucato, F; Altieri, GI; Noto, D; Valenti, V; Misiano, G; Giammanco, A; Fayer, F; Barbagallo, CM; Ganci, A; Cefalu, AB; Averna, M
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study
2020-01-01 Valenti V; Noto D; Giammanco A; Fayer F; Spina R; Altieri GI; Ingrassia V; Scrimali C; Barbagallo CM; Brucato F; Misiano G; Cefalu AB; Averna M.
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY
2013-01-01 Longo F; Panno D; Giammanco A; Altieri I; Di Pietra A; Portera D; Averna M; Barbagallo CM
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography
2021-01-01 Noto D.; Cefalu A.B.; Martinelli N.; Giammanco A.; Spina R.; Barbagallo C.M.; Caruso M.; Novo S.; Sarullo F.; Pernice V.; Brucato F.; Ingrassia V.; Fayer F.; Altieri G.I.; Scrimali C.; Misiano G.; Olivieri O.; Girelli D.; Averna M.